HOME >> BIOLOGY >> NEWS
Study provides insights on why some prostate cancer becomes resistant to hormone withdrawl therapy

SEATTLE -- A new study by scientists at Fred Hutchinson Cancer Research Center provides insight into why some men develop aggressive prostate cancer that becomes resistant to hormone-withdrawal therapy, a common form of treatment.

Researchers found that certain mutations in a protein called the androgen receptor cause advanced and invasive prostate cancer when put into otherwise healthy mice. The androgen receptor's normal function is to control growth of the prostate gland in response to cues from male hormones called androgens, which have long been thought to stimulate prostate tumors.

Because similarly defective androgen receptors have been found in prostate-cancer patients whose disease is resistant to hormone withdrawal, the finding sheds light on why most men with advanced prostate cancer treated with hormone-withdrawal therapy fail to be cured. The work opens the door to discovery of new, more effective therapies, according to Norman Greenberg, Ph.D., a member of Fred Hutchinson's Clinical Research Division.

The study is published in the Jan. 25, 2005 issue of the Proceedings of the National Academy of Sciences. The study was led by Dr. Guangzhou Han and colleagues.

Greenberg said that despite these and other earlier findings indicating a strong relationship between the androgen receptor and prostate cancer, no group had proved that it could be a key driver of disease.

"Our study is the first to demonstrate that if the androgen receptor acquires certain mutations, it can cause prostate cancer in otherwise healthy mice," he said. "Because very similar mutations have been found in androgen receptors from prostate-cancer patients whose disease is resistant to hormone-withdrawal therapy, we think this is a very significant finding."

The results suggest that prostate-cancer prevention trials involving drugs that lower a man's androgen levels should proceed cautiously, since complete androgen withdrawal seems to provide an env
'"/>

Contact: Dean Forbes
dforbes@fhcrc.org
206-667-2896
Fred Hutchinson Cancer Research Center
25-Jan-2005


Page: 1 2 3

Related biology news :

1. Study begins to reveal clues to the cause and progression of sepsis
2. Study finds gender differences in renal and other genes contributing to blood pressure
3. Study suggests estrogen deficiency can lead to obesity-induced high blood pressure after menopause
4. Study: Sticking to the sand might not be such good, clean fun for beachgoers
5. Study points to new way to predict death risk from torn aorta
6. Study identifies new gene therapy tools for inherited blindness
7. Study finds contaminated water reaching Floridas offshore keys
8. Study sheds light on why humans walk on two legs
9. Study explains how pathogens evolve to escape detection
10. Study finds hereditary link to premenstrual depression
11. Study identifies energy efficiency as reason for evolution of upright walking

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/7/2019)... ... November 07, 2019 , ... R3 Stem Cell is now offering its ... of 2019. The code to use during checkout is FIFTYOFF and applies to both ... nation’s leader in regenerative therapies with over 12,000 successful stem cell procedures performed nationwide. ...
(Date:11/5/2019)... ... 05, 2019 , ... Catalent, the leading global provider of ... consumer health products, today announced it will present at the upcoming World Orphan ... – 14, 2019. , On Wednesday, Nov. 13 at 3:20 p.m., Philip Wills, ...
(Date:10/30/2019)... CUMBERLAND FORESIDE, Maine (PRWEB) , ... October 29, ... ... UC4 linearity and calibration verification kits, for SIEMENS ATELLICA® analyzers, Order Numbers 701sa ... GLU, K, MG, NA, PHOS, UA, UTP, and UUN. , Each VALIDATE® kit, ...
Breaking Biology News(10 mins):
(Date:11/19/2019)... ... November 19, 2019 , ... Supercomputing Conference – Cirrascale ... for Autonomous Vehicle , Medical Imaging, and Natural Language Processing (NLP) workflows, ... Graphcore Poplar® software stack as part of its bare-metal cloud service offerings. In ...
(Date:11/12/2019)... ... 12, 2019 , ... Fiberstar, Inc., a global market leader ... a new innovative website. , After extensive research, Fiberstar revamped the ... updated ingredient usage tables by food application and video tutorials. And, this site ...
(Date:11/9/2019)... BOSTON (PRWEB) , ... November ... ... provider of artificial intelligence (AI)-powered technology for use in pathology research, today ... in liver biopsy samples from patients enrolled in the phase 3 selonsertib ...
(Date:11/5/2019)... N.J. (PRWEB) , ... November ... ... global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, ... its next-generation cell line development technology, GPEx® Boost. The technology enhances Catalent’s ...
Breaking Biology Technology:
Cached News: